Millennium Management’s Adial Pharmaceuticals ADIL Stock Holding History

Millennium Management’s Portfolio ADIL Stock Details ADIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-63	Closed	-$53K	–	7013
2022 Q2	$53K	Buy	+63	New	+$57K	﹤0.01%	6179
2022 Q1	–	Sell	-33	Closed	-$56K	–	6833
2021 Q4	$56K	Buy	33 +6	+22%	+$11.8K	﹤0.01%	6446
2021 Q3	$73K	Buy	+27	New	+$56.5K	﹤0.01%	6513
2019 Q2	–	Sell	-94	Closed	-$201K	–	3999
2019 Q1	$201K	Buy	+94	New	+$280K	﹤0.01%	3733
2018 Q4	–	Sell	-27	Closed	-$50K	–	3702
2018 Q3	$50K	Buy	+27	New	+$56K	﹤0.01%	3808

Other funds holding ADIL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Millennium Management's ADIL Position: Q3 2022 in Review

Millennium Management sold out of Adial Pharmaceuticals (ADIL) in Q3 2022, closing a stake of 63 shares — an estimated $53K sold.

Millennium Management first reported a position in ADIL in Q3 2018 and held it in 5 quarters. The position peaked at $201K in Q1 2019. 25 funds tracked by Wall St. Rank hold ADIL as of Q3 2022.

Millennium Management reported no remaining Adial Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 63 Adial Pharmaceuticals shares in Q3 2022, an estimated $53K.
Millennium Management first reported a position in Adial Pharmaceuticals in Q3 2018 and held it in 5 quarters.
Millennium Management's Adial Pharmaceuticals position peaked at $201K in Q1 2019.
25 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.